Skip to content

Intraocular Lens-shell Technique in Phacoemulsification

Intraocular Lens-Shell Technique: An Adjustment of Surgical Procedure Makes Differences in Treating Dense Nucleus Cataract

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02138123
Enrollment
80
Registered
2014-05-14
Start date
2011-12-31
Completion date
2013-06-30
Last updated
2014-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, Pseudoaphakia

Keywords

dense cataract, phacoemulsification, lens-shell technique, intraocular lens

Brief summary

In this study, the investigators introduce a surgical procedure called IOL-shell technique in the purpose of reduce complications of surgeries for dense cataract, and report a prospective randomized controlled study aiming at assessing efficacy and safety of the IOL-shell technique, which showed that the new procedure offered a safer way for hard cataract surgery over the conventional phacoemulsification procedure without compromise in efficacy.

Detailed description

A Prospective, randomized controlled study of 80 eyes with dense nucleus were enrolled. Patients were assigned to two groups: Group I: IOL was traditionally implanted after all nuclear fragments were completely removed, while in Group II, IOL was innovatively implanted in the bag before last residual nuclear fragment was removed. This novel adjusted surgical procedure, featured by using IOL as a protective barrier (named IOL-shell technique), not just as a refractive alternative, was conceptual different from the traditional step-by-step procedure. Clinical examinations including uncorrected visual acuity, central corneal thickness (CCT), temporal clear corneal thickness and the corneal endothelial cell density were carried out.

Interventions

PROCEDUREIOL-shell technique

Phacoemulsification was performed with the same device and handpieces, using the same phaco chop technique as in the conventional procedure group. What was different was that before the emulsification of the last nuclear fragment, cohesive viscoelastic material was injected below the nuclear fragment and a foldable IOL was implanted into the well inflated capsular bag posterior to the nuclear fragment. The remaining last piece of nuclear fragment was then emulsified and removed within the capsular bag.

In this procedure, a IOL was not implanted until all the nuclear fragments were removed.

Sponsors

National Natural Science Foundation of China
CollaboratorOTHER_GOV
Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Aged 50 years or above * Dense cataract cases were defined as eyes in which the nuclear color was graded IV or V according to the Lens Opacities Classification System III (LOCS III). Special attention was paid in selecting cases without apparent posterior cortical layer. * No central corneal opacification * Pupil diameter \>= 7 mm after full pharmacological dilation in preoperative assessment * A preoperative central endothelial cell count of \>= 1500 cells/mm2.

Exclusion criteria

* Participants with previous intraocular surgery * Abnormal lens zonules * Glaucoma * High myopia (\>-6.0 Diopters) * Pseudoexfoliation * Uveitis * Diabetes mellitus * Those who were not able to come for follow-up visits.

Design outcomes

Primary

MeasureTime frameDescription
Central corneal endothelial cell lossone monthCentral corneal endothelial cell loss was calculated by subtracting postoperative corneal endothelial cell density from the preoperative baseline level.

Secondary

MeasureTime frameDescription
central cornea thicknessone monthThe temporal corneal thickness and central corneal thickness were measured using the manual measurement scale in the scanning pictures of anterior segment optical coherence tomography preoperatively and at each postoperative visit.

Other

MeasureTime frameDescription
un-corrected visual acuityone monthThe un-corrected visual acuity was measured and recorded using an Early Treatment Diabetic Retinopathy Study chart both before operation and at the 1st, 7th and 30th day after operation.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026